Insider Transactions in Q1 2021 at Verona Pharma PLC (VRNA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2021
|
Lisa Deschamps Director |
BUY
Grant, award, or other acquisition
|
Direct |
116,000
+50.0%
|
-
|
|
Mar 01
2021
|
David Zaccardelli President and CEO |
SELL
Open market or private sale
|
Direct |
43,392
-0.22%
|
$43,392
$1.14 P/Share
|
|
Mar 01
2021
|
Mark W Hahn Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
26,728
-0.14%
|
$26,728
$1.14 P/Share
|
|
Feb 01
2021
|
Kenneth Cunningham Director |
SELL
Open market or private sale
|
Direct |
13,104
-14.12%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
David R Ebsworth Director |
SELL
Open market or private sale
|
Direct |
11,912
-1.68%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Martin Edwards Director |
SELL
Open market or private sale
|
Direct |
13,688
-10.01%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Mahendra Shah Director |
SELL
Open market or private sale
|
Direct |
10,800
-11.42%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Vikas Sinha Director |
SELL
Open market or private sale
|
Direct |
10,224
-10.8%
|
$0
$0.99 P/Share
|
|
Feb 01
2021
|
Anders Ullman Director |
SELL
Open market or private sale
|
Direct |
10,800
-3.02%
|
$0
$0.99 P/Share
|
|
Jan 28
2021
|
Mark W Hahn Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
105,824
+0.55%
|
-
|
|
Jan 28
2021
|
David Zaccardelli President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
529,104
+2.57%
|
-
|